Ads
related to: suggested yearly medication for horses basedchewy.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
Boldenone undecylenate, or boldenone undecenoate, sold under the brand names Equipoise and Parenabol among others, is an androgen and anabolic steroid (AAS) medication which is used in veterinary medicine, mainly in horses.
Tiludronic acid (INN; also known as tiludronate) is a bisphosphonate used for treatment of Paget's disease of bone (osteitis deformans) in human being medicine. It has the tradename Skelid. In veterinary medicine, tiludronic acid is used to treat navicular disease and bone spavin in horses. Its tradenames are Tildren and Equidronate.
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
The treatment of equine lameness is a complex subject. Lameness in horses has a variety of causes, and treatment must be tailored to the type and degree of injury, as well as the financial capabilities of the owner. Treatment may be applied locally, systemically, or intralesionally, and the strategy for treatment may change as healing progresses.
The nascent Horseracing Integrity and Safety Authority on Thursday released a draft of proposed anti-doping and medication control rules designed to bring uniformity to a sport that has operated ...
Flunixin is a nonsteroidal anti-inflammatory drug (NSAID), analgesic, and antipyretic used in horses, cattle and pigs. It is often formulated as the meglumine salt.In the United States, it is regulated by the U.S. Food and Drug Administration (FDA), and may only be lawfully distributed by order of a licensed veterinarian.
Daily cleaning is recommended in many management books, though if horses are on turnout and not being ridden, a weekly hoof check of healthy horses is often sufficient during good weather. Use of hoof oils, dressings, or other topical treatments varies by region, climate, and the needs of the individual horse.
Ponazuril (), sold by Merial, Inc., [1] now part of Boehringer Ingelheim, [2] under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidia Sarcocystis neurona.
Ads
related to: suggested yearly medication for horses basedchewy.com has been visited by 100K+ users in the past month